These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2805965)

  • 21. Irreversible hemorrhagic shock: treatment and cardiac pathophysiology.
    Markov AK; Oglethorpe N; Young DB; Hellems HK
    Circ Shock; 1981; 8(1):9-19. PubMed ID: 7237686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of exogenously administered fructose-1,6-diphosphate from ischemia reperfusion damage induced on isolated rat heart.
    Lazzarino G; Tavazzi B; Nuutinen M; Giardina B
    Ital J Biochem; 1989; 38(4):251A-253A. PubMed ID: 2583971
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemodynamic study of a single oral dose of enalapril in patients with heart failure].
    Zhi G; Huang DX; Yang XS
    Zhonghua Nei Ke Za Zhi; 1989 Sep; 28(9):534-6, 572. PubMed ID: 2560702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of fructose-1,6-diphosphate in essential headache. Therapeutic outlook and case study].
    Ferrigno V; Rotolo G; di Fede G; Rizzo G; Gullotti D; Sovarino R; Russo S; Rini GB
    G Clin Med; 1987 Oct; 68(10):515-8. PubMed ID: 3428516
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind study of the treatment of the adynamic ileus with fructose-1,6-diphosphate.
    Manani G; Valenti S; Segatto A; Giunta F; Maritano F; Nunziata A; Giron GP; Galzigna L
    Agressologie; 1982 Apr; 23(2):67-9. PubMed ID: 7048956
    [No Abstract]   [Full Text] [Related]  

  • 26. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
    Faggiano P; Rusconi C
    G Ital Cardiol; 1991 Nov; 21(11):1195-202. PubMed ID: 1809623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of ischemic renal injury with fructose 1,6-diphosphate.
    Didlake R; Kirchner KA; Lewin J; Bower JD; Markov AK
    J Surg Res; 1989 Sep; 47(3):220-6. PubMed ID: 2770278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of captopril in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Nicolin M; Streian C
    Med Interne; 1989; 27(2):99-105. PubMed ID: 2683008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
    Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effect of fructose-1,6-diphosphate in orthopedic surgical patients].
    Urso L; Brillante C; Orlandi M; Ballati S
    Minerva Anestesiol; 1982 Nov; 48(11):819-21. PubMed ID: 7162660
    [No Abstract]   [Full Text] [Related]  

  • 33. Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.
    Markov AK; Turner MD; Oglethorpe N; Neely WA; Hellems HK
    Surgery; 1981 Sep; 90(3):482-8. PubMed ID: 6455765
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarction.
    Marchionni N; Conti A; De Alfieri W; Di Bari M; Ferrucci L; Lombardi A; Moschi G; Pini R; Vannucci A
    Am J Cardiol; 1985 Aug; 56(4):266-9. PubMed ID: 4025164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ischaemia.
    Cacioli D; Clivati A; Pelosi P; Megevand J; Galeone M
    Curr Med Res Opin; 1988; 10(10):668-74. PubMed ID: 3371082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of alpha-naphthylthiourea-induced pulmonary edema with fructose-1,6-diphosphate.
    Markov AK; Causey AL; Didlake RH; Lemos LB
    Exp Lung Res; 2002 Jun; 28(4):285-99. PubMed ID: 12042031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
    Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of fructose 1,6-diphosphate on splanchnic artery occlusion shock in the rat.
    Squadrito F; Sturniolo R; Altavilla D; Campo GM; Trimarchi GR; Scuri R; Caputi AP
    Resuscitation; 1989 Dec; 18(2-3):299-307. PubMed ID: 2555881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.